Loading stock data…
$17.95-0.35 (-1.91%)
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States.
Omada Health, Inc. in the Healthcare sector is trading at $17.95 with a market capitalization of $1.4B. Wall Street consensus targets $28.42 (12 analysts), implying a +58.3% move over the next 12 months. The stock is currently 33% below its 52-week high of $26.91, remaining 2.6% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $87.83M↑ | $78.05M↑ | $75.85M↑ | $68.03M↑ | $61.37M |
| Gross Profit | $63.79M↑ | $48.69M↓ | $53.66M↑ | $45.07M↑ | $40.31M |
| Operating Income | $3.55M↑ | -$4.78M↓ | $3.28M↑ | -$2.51M↑ | -$4.34M |
| Net Income | $5.29M↑ | -$2.97M↓ | $5.16M↑ | -$3.18M↑ | -$5.31M |
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to ad...